Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
1.510
-0.070 (-4.43%)
At close: May 12, 2025, 4:00 PM
1.510
0.00 (0.00%)
After-hours: May 12, 2025, 4:56 PM EDT
Cellectis Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Cellectis stock have an average target of 7.00, with a low estimate of 5.00 and a high estimate of 10. The average target predicts an increase of 363.58% from the current stock price of 1.51.
Analyst Consensus: Buy
* Price targets were last updated on Nov 5, 2024.
Analyst Ratings
The average analyst rating for Cellectis stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $7 → $5 | Buy | Maintains | $7 → $5 | +231.13% | Nov 5, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $11 → $10 | Buy | Maintains | $11 → $10 | +562.25% | Jun 12, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $6 | Buy | Reiterates | $6 | +297.35% | May 31, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $6 | Buy | Reiterates | $6 | +297.35% | Nov 1, 2023 |
| Oppenheimer | Oppenheimer | Buy Reiterates $11 | Buy | Reiterates | $11 | +628.48% | Aug 8, 2023 |
Financial Forecast
Revenue This Year
73.10M
from 49.22M
Increased by 48.52%
Revenue Next Year
76.87M
from 73.10M
Increased by 5.17%
EPS This Year
-1.17
from -0.41
EPS Next Year
-0.87
from -1.17
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 150.1M | 139.6M | 65.1M | ||
| Avg | 73.1M | 76.9M | 63.9M | ||
| Low | 29.4M | 29.4M | 60.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 204.9% | 90.9% | -15.3% | ||
| Avg | 48.5% | 5.2% | -16.9% | ||
| Low | -40.3% | -59.8% | -21.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.80 | -0.30 | -1.92 |
| Avg | -1.17 | -0.87 | -1.88 |
| Low | -1.46 | -1.59 | -1.79 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.